SB269970 HCl

Names

[ CAS No. ]:
261901-57-9

[ Name ]:
SB269970 HCl

[Synonym ]:
(R)-3-[2-[2-(4-Methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol hydrochloride SB 269970A
SB-269970 (hydrochloride)

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₈H₂₉ClN₂O₃S

[ Molecular Weight ]:
388.95200

[ Exact Mass ]:
388.15900

[ PSA ]:
69.23000

[ LogP ]:
4.42590

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
H2O: soluble10mg/mL, clear (warmed to 60 °C)

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2935009090

Customs

[ HS Code ]: 2935009090

[ Summary ]:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

Articles

A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).

J. Med. Chem. 43(3) , 342-345, (2000)

Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.

Br. J. Pharmacol. 130(3) , 539-48, (2000)

The novel 5-HT(7) receptor antagonist, SB-269970-A, potently displaced [(3)H]-5-CT from human 5-HT(7(a)) (pK(i) 8.9+/-0.1) and 5-HT(7) receptors in guinea-pig cortex (pK(i) 8.3+/-0.2). 5-CT stimulated...

[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.

Br. J. Pharmacol. 130(2) , 409-17, (2000)

Binding of the 5-HT(7) receptor antagonist radioligand [(3)H]-SB-269970 to human 5-HT(7(a)) receptors expressed in HEK293 cell membranes (h5-HT(7(a))/293) and to guinea-pig cerebral cortex membranes, ...

Difelikefalin HCl
EPZ020411 HCl
Pazopanib HCl (GW786034 HCl)
Rosiglitazone HCl
ALAPROCLATE HCL
PD153035 HCl
2-{4-[2-(Propan-2-yl)pyrimidin-4-yl]piperazin-1-yl}-4-(pyridin-2-yl)pyrimidine
6-fluoro-2-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1,3-benzoxazole
4-Ethyl-5-fluoro-6-{4-[4-(pyridin-2-yl)pyrimidin-2-yl]piperazin-1-yl}pyrimidine
6-[4-(7-Fluoroquinazolin-4-yl)piperazin-1-yl]-2-methyl-2,3-dihydropyridazin-3-one
2-Methyl-6-[4-(4-methyl-1,3-benzothiazol-2-yl)piperazin-1-yl]-2,3-dihydropyridazin-3-one
4-(4-Chlorophenyl)-1-{5,6-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidin-4-ol
2-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]quinoxaline
1-[(3-Fluoropyridin-4-yl)methyl]-2-methyl-4-{5-methylpyrazolo[1,5-a]pyrimidin-7-yl}piperazine
6-(4-{2,5-Dimethylpyrazolo[1,5-a]pyrimidin-7-yl}-1,4-diazepan-1-yl)pyridazine-3-carbonitrile
1-{2-cyclopropyl-5H,6H,7H-cyclopenta[d]pyrimidin-4-yl}-4-[(2-methyl-1,3-oxazol-4-yl)methyl]piperazine

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.